{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:29:18Z","timestamp":1767706158950,"version":"3.41.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"am","delay-in-days":350,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"NIH NCI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pet.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.cpet.2025.01.004","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T21:55:33Z","timestamp":1739483733000},"page":"219-229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Updates in the Role of Positron Emission Tomography\/Computed Tomography in Radiation Oncology in Gastrointestinal Malignancies"],"prefix":"10.1016","volume":"20","author":[{"given":"Ritesh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Shalaby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshmi Rekha","family":"Narra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivani","family":"Gokhale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew P.","family":"Deek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salma K.","family":"Jabbour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cpet.2025.01.004_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"10.1016\/j.cpet.2025.01.004_bib2","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/cac2.12220","article-title":"A\u00a0global assessment of recent trends in gastrointestinal cancer and lifestyle-associated risk factors","volume":"41","author":"Lu","year":"2021","journal-title":"Cancer Commun (Lond)"},{"issue":"5","key":"10.1016\/j.cpet.2025.01.004_bib3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/j.semnuclmed.2021.04.001","article-title":"Variants and pitfalls in PET\/CT imaging of gastrointestinal cancers","volume":"51","author":"Jayaprakasam","year":"2021","journal-title":"Semin Nucl Med"},{"issue":"4","key":"10.1016\/j.cpet.2025.01.004_bib4","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1007\/s00261-020-02447-0","article-title":"Clinical impact of FDG PET\/CT in alimentary tract malignancies: an updated review","volume":"45","author":"Akin","year":"2020","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"10.1016\/j.cpet.2025.01.004_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/diagnostics13010053","article-title":"The role of positron emission tomography and computed tomographic (PET\/CT) imaging for radiation therapy planning: a literature review","volume":"13","author":"Mallum","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"2","key":"10.1016\/j.cpet.2025.01.004_bib6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4103\/0019-509X.63000","article-title":"PET\/CT-guided radiation therapy planning: from present to the future","volume":"47","author":"Gupta","year":"2010","journal-title":"Indian J Cancer"},{"key":"10.1016\/j.cpet.2025.01.004_bib7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.critrevonc.2019.01.011","article-title":"Positron emission tomography with computed tomography imaging (PET\/CT) for the radiotherapy planning definition of the biological target volume: part 1","volume":"140","author":"Alongi","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.cpet.2025.01.004_bib8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1245\/s10434-009-0719-7","article-title":"Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma","volume":"17","author":"Hyun","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.cpet.2025.01.004_bib9","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.radonc.2006.02.014","article-title":"A\u00a0prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer","volume":"78","author":"Leong","year":"2006","journal-title":"Radiother Oncol"},{"issue":"11","key":"10.1016\/j.cpet.2025.01.004_bib10","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1007\/s12094-018-1879-3","article-title":"Radiotherapy volume delineation using 18F-FDG-PET\/CT modifies gross node volume in patients with oesophageal cancer","volume":"20","author":"Jimenez-Jimenez","year":"2018","journal-title":"Clin Transl Oncol"},{"issue":"4","key":"10.1016\/j.cpet.2025.01.004_bib11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.6004\/jnccn.2023.0019","article-title":"Esophageal and esophagogastric junction cancers, version 2.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Ajani","year":"2023","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"3","key":"10.1016\/j.cpet.2025.01.004_bib12","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00259-008-0959-y","article-title":"Positron emission tomography changes management and prognostic stratification in patients with oesophageal cancer: results of a multicentre prospective study","volume":"36","author":"Chatterton","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.cpet.2025.01.004_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/cncr.22397","article-title":"Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy","volume":"109","author":"Bruzzi","year":"2007","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.cpet.2025.01.004_bib14","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ijrobp.2015.03.030","article-title":"Expert consensus contouring guidelines for intensity modulated radiation therapy in esophageal and gastroesophageal junction cancer","volume":"92","author":"Wu","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"25","key":"10.1016\/j.cpet.2025.01.004_bib15","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1200\/JCO.20.03611","article-title":"Randomized phase II study of PET response-adapted combined modality therapy for esophageal cancer: mature results of the CALGB 80803 (alliance) trial","volume":"39","author":"Goodman","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.cpet.2025.01.004_bib16","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1470-2045(07)70244-9","article-title":"PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial","volume":"8","author":"Lordick","year":"2007","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.cpet.2025.01.004_bib17","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2967\/jnumed.110.085803","article-title":"(18)F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trial","volume":"52","author":"zum B\u00fcschenfelde","year":"2011","journal-title":"J\u00a0Nucl Med"},{"issue":"7","key":"10.1016\/j.cpet.2025.01.004_bib18","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S1470-2045(18)30201-8","article-title":"Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study","volume":"19","author":"Noordman","year":"2018","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.cpet.2025.01.004_bib19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12885-018-4034-1","article-title":"Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial","volume":"18","author":"Noordman","year":"2018","journal-title":"BMC Cancer"},{"issue":"23","key":"10.1016\/j.cpet.2025.01.004_bib20","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1200\/JCO.20.00866","article-title":"Treatment of locally advanced esophageal carcinoma: ASCO guideline","volume":"38","author":"Shah","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.cpet.2025.01.004_bib21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/SLA.0000000000004930","article-title":"Chemoradiotherapy followed by active surveillance versus standard esophagectomy for esophageal cancer: a systematic review and individual patient data meta-analysis","volume":"275","author":"van der Wilk","year":"2022","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.cpet.2025.01.004_bib22","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s00259-002-1029-5","article-title":"FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings","volume":"30","author":"Stahl","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"10.1016\/j.cpet.2025.01.004_bib23","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/cncr.21074","article-title":"Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography","volume":"103","author":"Chen","year":"2005","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.cpet.2025.01.004_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1148\/rg.261055078","article-title":"CT and PET in stomach cancer: preoperative staging and monitoring of response to therapy","volume":"26","author":"Lim","year":"2006","journal-title":"Radiographics"},{"issue":"10","key":"10.1016\/j.cpet.2025.01.004_bib25","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa010187","article-title":"Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction","volume":"345","author":"Macdonald","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.cpet.2025.01.004_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/srao.2002.30827","article-title":"Radiation treatment parameters in the adjuvant postoperative therapy of gastric cancer","volume":"12","author":"Tepper","year":"2002","journal-title":"Semin Radiat Oncol"},{"issue":"2","key":"10.1016\/j.cpet.2025.01.004_bib27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0360-3016(01)02646-3","article-title":"Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation","volume":"52","author":"Smalley","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.cpet.2025.01.004_bib28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cpet.2023.12.004","article-title":"Role of PET\/computed tomography in gastric and colorectal malignancies","volume":"19","author":"Khandelwal","year":"2024","journal-title":"Pet Clin"},{"issue":"1","key":"10.1016\/j.cpet.2025.01.004_bib29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/j.gastro.2013.11.004","article-title":"Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic association","volume":"146","author":"Al-Hawary","year":"2014","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cpet.2025.01.004_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/RMR.0b013e3181b48392","article-title":"Magnetic resonance imaging of adenocarcinoma of the pancreas","volume":"20","author":"Vachiranubhap","year":"2009","journal-title":"Top Magn Reson Imaging"},{"issue":"9","key":"10.1016\/j.cpet.2025.01.004_bib31","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1245\/s10434-008-9992-0","article-title":"PET\/CT fusion scan enhances CT staging in patients with pancreatic neoplasms","volume":"15","author":"Farma","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.cpet.2025.01.004_bib32","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1200\/JCO.21.02233","article-title":"Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: long-term results of the Dutch randomized PREOPANC trial","volume":"40","author":"Versteijne","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.cpet.2025.01.004_bib33","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/jamaoncol.2022.2319","article-title":"Efficacy of preoperative mFOLFIRINOX vs mFOLFIRINOX plus hypofractionated radiotherapy for borderline resectable adenocarcinoma of the pancreas: the A021501 phase 2 randomized clinical trial","volume":"8","author":"Katz","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.cpet.2025.01.004_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110064","article-title":"Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: a multi-center, open-label phase 2 study","volume":"191","author":"Chuong","year":"2024","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.cpet.2025.01.004_bib35","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s11307-009-0271-7","article-title":"Performance of integrated FDG-PET\/contrast-enhanced CT in the diagnosis of recurrent pancreatic cancer: comparison with integrated FDG-PET\/non-contrast-enhanced CT and enhanced CT","volume":"12","author":"Kitajima","year":"2010","journal-title":"Mol Imaging Biol"},{"issue":"1","key":"10.1016\/j.cpet.2025.01.004_bib36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1756-9966-27-41","article-title":"Comparison of CT and PET-CT based planning of radiation therapy in locally advanced pancreatic carcinoma","volume":"27","author":"Topkan","year":"2008","journal-title":"J\u00a0Exp Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.cpet.2025.01.004_bib37","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/annonc\/mdw020","article-title":"Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas","volume":"27","author":"Ramanathan","year":"2016","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.cpet.2025.01.004_bib38","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.ejso.2020.02.002","article-title":"Prognostic value of 18FDG PET\/CT volumetric parameters in the survival prediction of patients with pancreatic cancer","volume":"46","author":"Mohamed","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.cpet.2025.01.004_bib39","first-page":"2169","article-title":"Prognostic implications of 18-FDG positron emission tomography\/computed tomography in resectable pancreatic cancer","volume":"9","author":"Sperti","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"2","key":"10.1016\/j.cpet.2025.01.004_bib40","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1245\/s10434-018-07098-6","article-title":"Significance of 18F-fluorodeoxyglucose (FDG) uptake in response to chemoradiotherapy for pancreatic cancer","volume":"26","author":"Kurahara","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.cpet.2025.01.004_bib41","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/01.sla.0000172095.97787.84","article-title":"Positron emission tomography\/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness","volume":"242","author":"Heinrich","year":"2005","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.cpet.2025.01.004_bib42","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/jso.26854","article-title":"Prediction of local tumor control and recurrence-free survival in patients with pancreatic cancer undergoing curative resection after neoadjuvant chemoradiotherapy","volume":"126","author":"Suto","year":"2022","journal-title":"J\u00a0Surg Oncol"},{"issue":"7","key":"10.1016\/j.cpet.2025.01.004_bib43","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s12149-021-01629-0","article-title":"The role of FDG PET\/CT or PET\/MR imaging in assessing response to neoadjuvant therapy for patients with borderline or resectable pancreatic cancer: a systematic literature review","volume":"35","author":"Evangelista","year":"2021","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.cpet.2025.01.004_bib44","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.24.01160","article-title":"Management of locally advanced rectal cancer: ASCO guideline","author":"Scott","year":"2024","journal-title":"J\u00a0Clin Oncol"},{"issue":"15","key":"10.1016\/j.cpet.2025.01.004_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512159","article-title":"Total neoadjuvant treatment for locally advanced rectal cancer patients: where do we stand?","volume":"24","author":"Dapr\u00e0","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.cpet.2025.01.004_bib46","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.radonc.2011.12.016","article-title":"FDG-PET-CT reduces the interobserver variability in rectal tumor delineation","volume":"102","author":"Buijsen","year":"2012","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.cpet.2025.01.004_bib47","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.ejso.2021.12.019","article-title":"Prospective study to assess the role of FDG PET\/CT in detecting systemic metastatic spread in rectal cancers with lateral pelvic lymph nodes","volume":"48","author":"Agrawal","year":"2022","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.cpet.2025.01.004_bib48","first-page":"424","article-title":"DWI-MR and PET-CT functional imaging for boost tumor volume delineation in neoadjuvant rectal cancer treatment","volume":"37","author":"Rosa","year":"2023","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.cpet.2025.01.004_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102796","article-title":"Oncological risks associated with the planned watch-and-wait strategy using total neoadjuvant treatment for rectal cancer: a narrative review","volume":"129","author":"Socha","year":"2024","journal-title":"Cancer Treat Rev"},{"issue":"10139","key":"10.1016\/j.cpet.2025.01.004_bib50","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","article-title":"Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study","volume":"391","author":"van der Valk","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cpet.2025.01.004_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1037783","article-title":"The reduction of 18F-FDG uptake ability of tumor tissue after neoadjuvant chemoradiotherapy in locally advanced rectal cancer can effectively reflect the degree of tumor regression","volume":"12","author":"Wu","year":"2022","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.cpet.2025.01.004_bib52","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF02586980","article-title":"Combined therapy for cancer of the anal canal: a preliminary report","volume":"17","author":"Nigro","year":"1974","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"10.1016\/j.cpet.2025.01.004_bib53","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"Bartelink","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.cpet.2025.01.004_bib54","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00259-023-06393-z","article-title":"[18F]-FDG PET in anal canal cancer: a systematic review and meta-analysis","volume":"51","author":"Mirshahvalad","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.cpet.2025.01.004_bib55","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/sj.bjc.6604897","article-title":"The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer","volume":"100","author":"de Winton","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cpet.2025.01.004_bib56","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.critrevonc.2018.03.013","article-title":"Positron emission tomography and computed tomographic (PET\/CT) imaging for radiation therapy planning in anal cancer: a systematic review and meta-analysis","volume":"126","author":"Albertsson","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"issue":"9","key":"10.1016\/j.cpet.2025.01.004_bib57","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.3390\/cancers13092099","article-title":"De-escalation of therapy for patients with early-stage squamous cell carcinoma of the anus","volume":"13","author":"Miller","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.cpet.2025.01.004_bib58","doi-asserted-by":"crossref","first-page":"653","DOI":"10.6004\/jnccn.2023.0030","article-title":"Anal carcinoma, version 2.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Benson","year":"2023","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.cpet.2025.01.004_bib59","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijrobp.2007.09.005","article-title":"Tumor response and survival predicted by post-therapy FDG-PET\/CT in anal cancer","volume":"71","author":"Schwarz","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.cpet.2025.01.004_bib60","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1470-2045(17)30071-2","article-title":"Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial","volume":"18","author":"Glynne-Jones","year":"2017","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.cpet.2025.01.004_bib61","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1007\/s00261-023-03897-y","article-title":"PET\/MR imaging in colorectal and anal cancers: an update","volume":"48","author":"Jayaprakasam","year":"2023","journal-title":"Abdom Radiol (NY)"},{"issue":"3","key":"10.1016\/j.cpet.2025.01.004_bib62","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1053\/j.semnuclmed.2021.11.012","article-title":"Clinical use of PET\/MR in oncology: an update","volume":"52","author":"Seifert","year":"2022","journal-title":"Semin Nucl Med"},{"issue":"3","key":"10.1016\/j.cpet.2025.01.004_bib63","first-page":"237","article-title":"[Application of PET-LINAC in biology-guided radiotherapy]","volume":"47","author":"Yang","year":"2023","journal-title":"Zhongguo Yi Liao Qi Xie Za Zhi"}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859825000045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859825000045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T17:04:18Z","timestamp":1750179858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556859825000045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1556859825000045"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2025.01.004","relation":{},"ISSN":["1556-8598"],"issn-type":[{"type":"print","value":"1556-8598"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updates in the Role of Positron Emission Tomography\/Computed Tomography in Radiation Oncology in Gastrointestinal Malignancies","name":"articletitle","label":"Article Title"},{"value":"PET Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpet.2025.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}